Education
About Us
Working with TipRanks
Follow Us
Acura Pharmaceuticals (ACUR)
OTHER OTC:ACUR
Total Valuation
Acura Pharmaceuticals has a market cap or net worth of $1.32M. The enterprise value is ―.
Market Cap$1.32M
Enterprise Value―
Share Statistics
Acura Pharmaceuticals has 66,001,785 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding66,001,785
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Acura Pharmaceuticals’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)0.00
Return on Assets (ROA)0.00
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)0.00
Revenue Per Employee0.00
Profits Per Employee0.00
Employee Count9
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Acura Pharmaceuticals is 0.00. Acura Pharmaceuticals’s PEG ratio is ―.
PE Ratio0.00
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.00
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio―
Income Statement
In the last 12 months, Acura Pharmaceuticals had revenue of 0.00 and earned 0.00 in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit0.00
Operating Income0.00
Pretax Income0.00
Net Income0.00
EBITDA0.00
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Acura Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-7.67
52-Week Price Change100.00%
50-Day Moving Average0.02
200-Day Moving Average―
Relative Strength Index (RSI)43.28
Average Volume (3m)226.00
Important Dates
Acura Pharmaceuticals upcoming earnings date is Nov 14, 2022, TBA Not Confirmed.
Last Earnings DateAug 15, 2022
Next Earnings DateNov 14, 2022
Ex-Dividend Date―
Financial Position
Acura Pharmaceuticals as a current ratio of 0.00, with Debt / Equity ratio of 0.00%
Current Ratio0.00
Quick Ratio0.00
Debt to Market Cap0.00
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Acura Pharmaceuticals has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Acura Pharmaceuticals EV to EBITDA ratio is 0.00, with an EV/FCF ratio of 0.00.
EV to Sales0.00
EV to EBITDA0.00
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
Acura Pharmaceuticals has $0.00 in cash and marketable securities with $0.00 in debt, giving a net cash position of $0.00 billion.
Cash & Marketable Securities$0.00
Total Debt$0.00
Net Cash$0.00
Net Cash Per Share$0.00
Tangible Book Value Per Share$0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Acura Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―